61 results
Page 3 of 4
6-K
EX-99.1
9cklv02x5rs
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.2
6vk89vx3na7d1aam6
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.1
37jqo40x9mwko
3 Jun 21
Development program exploring the potential of CBP-174 in the treatment of chronic inflammatory pruritus
6:04am
6-K
24ymf4o9
3 Jun 21
Development program exploring the potential of CBP-174 in the treatment of chronic inflammatory pruritus
6:04am
6-K
EX-99.2
47ttroz 5uxwrv
3 Jun 21
Development program exploring the potential of CBP-174 in the treatment of chronic inflammatory pruritus
6:04am
6-K
EX-99.1
w89q35iuazrr
17 May 21
Connect Biopharma Announces First
5:27pm
424B4
p1zyku5lz dyvuait
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
jfk6hqo
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
tdne0
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-99.1
818chn6vb
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
iqegi7xwf1jd4
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.9
xem k6l22dwq3rgwm
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.15
fzb97jco9 k629o9qw
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.10
g8fha obeh1
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.13
x5deia rg
26 Feb 21
Registration statement (foreign)
4:56pm
DRSLTR
iwkv6w 9t9b9r95jyyc
26 Jan 21
Correspondence regarding draft registration statement
12:00am
DRS/A
b9suckvdtgb jen
26 Jan 21
Draft registration statement (amended)
12:00am
UPLOAD
5meqpmqx
13 Jan 21
Letter from SEC
12:00am
DRS
3qydvq znsa3q6
17 Dec 20
Draft registration statement
12:00am
DRS
EX-10.7
1qsjumlv0d8wt
17 Dec 20
Draft registration statement
12:00am